IP Library Granted Patent US 7,910,382
Granted Patent B2
US 7,910,382 · App. 11/555,103 · Granted Mar 22, 2011

Device and methods for liquid crystal-based bioagent detection

Assignee: Wisconsin Alumni Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,910,382
App. No.
11/555,103
Granted
Mar 22, 2011
Kind
B2
Abstract

The present invention provides liquid crystal-based devices and methods for bioagent detection. In certain aspects, the present invention is directed to devices and methods utilizing liquid crystals and membranes containing polymerized targets that can report the presence of bioagents including, but not limited to, enzymes, antibodies, and toxins.

Claims (16)

1. A liquid crystal device for detecting the presence of a bioagent in a sample, comprising:

(a) a liquid crystal;

(b) an aqueous phase positioned such that an interface exists between the liquid crystal and said aqueous phase; and

(c) a membrane located at the interface containing a polymerized target of a bioagent, said polymerized target comprising a target of the bioagent covalently cross-linked to a polymer network, wherein interaction of said bioagent with the polymerized target causes an orientation change in said liquid crystal thereby indicating the presence of the bioagent in the sample.

2. The liquid crystal device according to claim 1 wherein said bioagent is an enzyme and the target is a substrate for the enzyme.

3. The liquid crystal device according to claim 1 wherein said bioagent is an antibody and the target is an antigen recognized by said antibody.

4. The liquid crystal device according to claim 1 wherein said bioagent is an antigen and the target is an antibody that recognizes said antigen.

5. The liquid crystal device according to claim 1 wherein the polymer network comprises a non-target molecule that is cross-linked to said target.

6. The liquid crystal device according to claim 5 , wherein the non-target molecule is a polymer.

7. The liquid crystal device according to claim 1 , wherein the aqueous phase comprises an enhancing agent that enhances the change in orientation of the liquid crystal upon interaction of the bioagent and target.

8. The liquid crystal device according to claim 7 wherein the enhancing agent is dilauroyl phosohatidylcholine (DLPC).

9. The liquid crystal device according to claim 1 , further comprising a cross-linking agent.

10. A liquid crystal device for detecting the presence of a bioagent in a sample, comprising:

(a) a liquid crystal;

(b) an aqueous phase positioned such that an interface exists between the liquid crystal and said aqueous phase; and

(c) a polymerized membrane comprising a polymer cross-linked to a target of a bioagent, said polymerized membrane located at the interface between the liquid crystal and said aqueous phase wherein interaction of said bioagent with the target causes an orientation change in said liquid crystal thereby indicating the presence of the bioagent in the sample.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 19, 2011
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: NAVY, SECRETARY OF THE UNITED STATES OF AMERICA
Reel/Frame 026209/0072 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2007
From: BEEBE, DAVID; TEREN, SARAH; PARK, JOON-SEO; ABBOTT, NICHOLAS; JOHNSON, ERIC
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 019351/0489 →
Continuity (2)
Provisional Application 60731824 · Oct 31, 2005
Related Publication 20070231832A1 · Oct 4, 2007